3, hb cis dihydrotetrabanezine for the treatment of schizophrenia and other psychoses

Details for Australian Patent Application No. 2006277753 (hide)

International Classifications

Event Publications

3 April 2008 PCT application entered the National Phase

PCT publication WO2007/017654 Priority application(s): WO2007/017654

1 October 2009 Assignment before Grant

Cambridge Laboratories (Ireland) Limited The application has been assigned to Biovail Laboratories International (Barbados) SRL

10 November 2011 Application Accepted

Published as AU-B-2006277753

15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.